Lineage Cell Therapeutics Inc (LCTX)
1.05
+0.04
(+3.96%)
USD |
NYAM |
May 22, 16:00
1.055
0.00 (0.00%)
After-Hours: 20:00
Lineage Cell Therapeutics Debt to Equity Ratio: 0.00 for March 31, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|---|
March 31, 2024 | 0.00 |
December 31, 2023 | 0.00 |
September 30, 2023 | 0.00 |
June 30, 2023 | 0.00 |
March 31, 2023 | 0.00 |
December 31, 2022 | 0.00 |
September 30, 2022 | 0.00 |
June 30, 2022 | 0.00 |
March 31, 2022 | 0.00 |
December 31, 2021 | 0.00 |
September 30, 2021 | 0.00 |
June 30, 2021 | 0.00 |
March 31, 2021 | 0.0044 |
December 31, 2020 | 0.0054 |
September 30, 2020 | 0.0057 |
June 30, 2020 | 0.0053 |
March 31, 2020 | 0.00 |
December 31, 2019 | 0.00 |
September 30, 2019 | 0.00 |
June 30, 2019 | 0.00 |
March 31, 2019 | 0.0001 |
December 31, 2018 | 0.0007 |
September 30, 2018 | 0.0004 |
June 30, 2018 | 0.0012 |
March 31, 2018 | 0.0012 |
Date | Value |
---|---|
December 31, 2017 | 0.001 |
September 30, 2017 | 0.0009 |
June 30, 2017 | 0.0158 |
March 31, 2017 | 0.0126 |
December 31, 2016 | 0.0177 |
September 30, 2016 | 0.0132 |
June 30, 2016 | 0.0113 |
March 31, 2016 | 0.0653 |
December 31, 2015 | 0.0248 |
September 30, 2015 | 0.0474 |
June 30, 2015 | 0.014 |
March 31, 2015 | 0.0065 |
December 31, 2014 | 0.0016 |
September 30, 2014 | 0.0003 |
June 30, 2014 | 0.00 |
March 31, 2014 | 0.00 |
December 31, 2013 | 0.00 |
September 30, 2013 | 0.00 |
June 30, 2013 | 0.00 |
March 31, 2013 | 0.00 |
December 31, 2012 | 0.00 |
September 30, 2012 | 0.00 |
June 30, 2012 | 0.00 |
March 31, 2012 | 0.00 |
December 31, 2011 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Jun 2019
0.0057
Maximum
Sep 2020
0.001
Average
--
Median
Jun 2019
Debt to Equity Ratio Benchmarks
Acumen Pharmaceuticals Inc | -- |
Sarepta Therapeutics Inc | 1.289 |
CEL-SCI Corp | -- |
AIM ImmunoTech Inc | 0.5332 |
IGC Pharma Inc | 0.0152 |
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 108.48M |
Total Liabilities (Quarterly) | 37.49M |
Shareholders Equity (Quarterly) | 72.40M |
Current Ratio | 2.707 |